Dr. Ron Najafi CEO of NovaBay Presents at Bio.org CEO & Investor Conference NYC 2014 (NYSE:NBY)

Stock-Sector Interview with NovaBay CEO Highlights Prospects for the Company’s FDA-Cleared,  Advanced Wound Cleanser, NeutroPhase®, and its Development Pipeline.

New York, NY – March 5, 2014 – Stock-Sector.com, an online source of news about promising medical,  technology and energy companies, today announced that it is releasing a video interview with  Dr. Ron Najafi, Chairman and CEO of NovaBay Pharmaceuticals (NYSE: NBY), an Emeryville, CA  biopharmaceutical company developing novel, topical, anti...

Read more...

NovaBay (NYSE MKT: NBY) May Improve Lives of Patients with Indwelling Catheters

Research Breakthrough in Catheter Irrigation 

NovaBay released a full story on one of the patients enrolled in its recently-completed clinical trial of Auriclosene to prevent urinary catheter blockage and encrustation.  Overall, 
the top-line results demonstrated that Auriclosene irrigation solution was effective at reducing the degree of catheter encrustation and maintaining the catheter patency over the course of the study.  Primary endpoints in the study were achieved showing statistically sign...

Read more...

German TV: Snowden Says NSA Also Spies on Industry

BERLIN January 27, 2014 (AP) -  By KIRSTEN GRIESHABER Associated Press

Former NSA contractor Edward Snowden claimed in a new interview that the U.S. agency is involved in industrial espionage.

In the interview aired Sunday night on German public television broadcaster ARD, Snowden said if German engineering company Siemens had information that would benefit the U.S., but had nothing to do with national security needs, the National Security Agency would still use it.

It wasn't clear what exactly Snow...

Read more...